Glucocorticoid independent mediation of interleukin-1 induced changes in serum zinc and liver metallothionein levels

Life Sci. 1984 Nov 19;35(21):2113-8. doi: 10.1016/0024-3205(84)90510-1.

Abstract

Interleukin-1 (IL-1) causes changes in zinc metabolism which have been attributed to mediation, at least in part, by glucocorticoids. However, IL-1 was found to actually lower serum corticosterone levels in rats. In addition, adrenalectomy only partially inhibited the ability of IL-1 to depress serum zinc levels and increase the amount of zinc associated with hepatic metallothionein. Furthermore, IL-1 increased total liver metallothionein protein to similar levels in both adrenalectomized and normal rats. Administering the synthetic glucocorticoid dexamethasone with IL-1 to adrenalectomized rats produced additive, but not synergistic effects on serum zinc and metallothionein concentrations. Studies with actinomycin D suggested that IL-1 induction of metallothionein might involve glucagon.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenalectomy
  • Animals
  • Dactinomycin / pharmacology
  • Dexamethasone / pharmacology
  • Glucocorticoids / physiology*
  • Interleukin-1 / physiology*
  • Liver / drug effects
  • Liver / metabolism*
  • Male
  • Metallothionein / metabolism*
  • Rats
  • Zinc / blood*

Substances

  • Glucocorticoids
  • Interleukin-1
  • Dactinomycin
  • Dexamethasone
  • Metallothionein
  • Zinc